VIN Portfolio Company Highlight: BiologicsMD | Wednesday, January 28th at 11:00 AM CT
BiologicsMD is an early-stage clinical therapeutics company advancing targeted biologics for hair growth, with additional programs in bone health and oncology. Our lead program is designed to stimulate durable hair regrowth through localized activation of the natural hair cycle, with early human data providing exciting, albeit preliminary, results.
By precisely directing therapies to the tissue where they are needed, our platform is designed to improve patient outcomes and safety profiles in order to unlock meaningful clinical and commercial advantages. BiologicsMD is building a differentiated pipeline around this approach, with the potential to address large unmet needs in hair loss and beyond.
